Novel Application for Imaging Agents


Compounds and methods related to NIR molecular imaging, in-vitro and in-vivo functional imaging, therapy/efficacy monitoring, and cancer and metastatic activity imaging. Compounds and methods demonstrated pertain to the field of peripheral benzodiazepine receptor imaging, metabolic imaging, cellular respiration imaging, cellular proliferation imaging as targeted agents that incorporate signaling agents.


U.S. Patent 7,754,884: Targeted, NIR imaging agents for therapy efficacy monitoring, deep tissue disease demarcation and deep tissue imaging

U.S. Patent 8,188,116: Agents for therapy efficacy monitoring and deep tissue imaging

Darryl BornhopH. Charles ManningMingfeng BaiShelby Wyatt
Licensing manager: 
Taylor Jordan

Featured Video

Vanderbilt Patent Activity

View Vanderbilt University Patents

CTTC on Twitter